To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

NCT06703710 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JW2286
DRUG: Placebo of JW2286

Sponsor

JW Pharmaceutical